| Product Code: ETC13191300 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Parkinson's Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Parkinson's Disease Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Parkinson's Disease Market Revenues & Volume, 2021 & 2031F |
3.3 North America Parkinson's Disease Market - Industry Life Cycle |
3.4 North America Parkinson's Disease Market - Porter's Five Forces |
3.5 North America Parkinson's Disease Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Parkinson's Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 North America Parkinson's Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.8 North America Parkinson's Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 North America Parkinson's Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 North America Parkinson's Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 North America Parkinson's Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Parkinson's Disease Market Trends |
6 North America Parkinson's Disease Market, 2021 - 2031 |
6.1 North America Parkinson's Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Parkinson's Disease Market, Revenues & Volume, By Levodopa/Carbidopa, 2021 - 2031 |
6.1.3 North America Parkinson's Disease Market, Revenues & Volume, By Dopamine Receptor Agonists, 2021 - 2031 |
6.1.4 North America Parkinson's Disease Market, Revenues & Volume, By MAO-Inhibitors, 2021 - 2031 |
6.1.5 North America Parkinson's Disease Market, Revenues & Volume, By COMT-Inhibitors, 2021 - 2031 |
6.1.6 North America Parkinson's Disease Market, Revenues & Volume, By Anticholinergics, 2021 - 2031 |
6.1.7 North America Parkinson's Disease Market, Revenues & Volume, By Other Drugs, 2021 - 2031 |
6.2 North America Parkinson's Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Parkinson's Disease Market, Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021 - 2031 |
6.2.3 North America Parkinson's Disease Market, Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021 - 2031 |
6.3 North America Parkinson's Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Parkinson's Disease Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 North America Parkinson's Disease Market, Revenues & Volume, By Transdermal, 2021 - 2031 |
6.3.4 North America Parkinson's Disease Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3.5 North America Parkinson's Disease Market, Revenues & Volume, By Intestinal Infusion, 2021 - 2031 |
6.3.6 North America Parkinson's Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Parkinson's Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.2 North America Parkinson's Disease Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 North America Parkinson's Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Parkinson's Disease Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.5 North America Parkinson's Disease Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.5 North America Parkinson's Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Parkinson's Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Parkinson's Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 North America Parkinson's Disease Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Parkinson's Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.1 United States (US) Parkinson's Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.2 Canada Parkinson's Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.3 Rest of North America Parkinson's Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3 North America Parkinson's Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
7.3.1 United States (US) Parkinson's Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.2 Canada Parkinson's Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.3 Rest of North America Parkinson's Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.4 North America Parkinson's Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.1 United States (US) Parkinson's Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.2 Canada Parkinson's Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.3 Rest of North America Parkinson's Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Parkinson's Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 United States (US) Parkinson's Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Canada Parkinson's Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Rest of North America Parkinson's Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 North America Parkinson's Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.1 United States (US) Parkinson's Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.2 Canada Parkinson's Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.3 Rest of North America Parkinson's Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
8 North America Parkinson's Disease Market Key Performance Indicators |
9 North America Parkinson's Disease Market - Export/Import By Countries Assessment |
10 North America Parkinson's Disease Market - Opportunity Assessment |
10.1 North America Parkinson's Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Parkinson's Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.3 North America Parkinson's Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
10.4 North America Parkinson's Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.5 North America Parkinson's Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.6 North America Parkinson's Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
11 North America Parkinson's Disease Market - Competitive Landscape |
11.1 North America Parkinson's Disease Market Revenue Share, By Companies, 2022 |
11.2 North America Parkinson's Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here